Jacobs Levy Equity Management Inc. cut its holdings in Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 10.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 504,784 shares of the company’s stock after selling 57,553 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.88% of Molina Healthcare worth $173,928,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in MOH. True Wealth Design LLC raised its position in Molina Healthcare by 2,500.0% during the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Innealta Capital LLC bought a new position in shares of Molina Healthcare during the second quarter valued at about $36,000. Ashton Thomas Private Wealth LLC purchased a new stake in Molina Healthcare in the second quarter worth about $40,000. Capital Performance Advisors LLP bought a new position in Molina Healthcare during the third quarter valued at approximately $62,000. Finally, AM Squared Ltd bought a new stake in shares of Molina Healthcare during the 2nd quarter valued at $59,000. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Price Performance
MOH opened at $301.87 on Tuesday. The company has a quick ratio of 1.55, a current ratio of 1.54 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $17.27 billion, a P/E ratio of 15.33, a PEG ratio of 1.03 and a beta of 0.54. Molina Healthcare, Inc. has a 12-month low of $272.69 and a 12-month high of $423.92. The stock has a fifty day moving average of $316.48 and a 200-day moving average of $321.52.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on MOH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 price objective on shares of Molina Healthcare in a research report on Thursday, October 24th. Robert W. Baird reduced their price objective on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Barclays increased their price target on Molina Healthcare from $359.00 to $372.00 and gave the company an “equal weight” rating in a report on Friday, October 25th. StockNews.com upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. Finally, Wells Fargo & Company boosted their price objective on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $367.17.
Read Our Latest Stock Analysis on MOH
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Roku’s Recovery Prospects: Why 2025 Could Be a Game-Changer
- What are earnings reports?
- 3 Hot Buyback Announcements That Will Drive Value in 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- Can HPE Keep Rising Through 2025? The U.S. Government May Decide
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.